GTx, Inc. (GTXI) Downgraded by Zacks Investment Research to Hold

GTx, Inc. (GTXI) Downgraded by Zacks Investment Research to Hold

According to Zacks, “GTx, Inc. is a biopharmaceutical company dedicated to the discovery, development and commercialization of small molecules for the treatment of cancer, including treatments for breast and prostate cancer, and other serious medical …

(Visited 1 times, 1 visits today)
3
Like
Save

Comments

Comments are disabled for this post.